Shared care

The drugs below have been classified as Amber, suitable for initiation by a hospital specialist before prescribing responsibility is transferred to the patients' GP. Responsibilities for the hospital specialist and the GP are laid out in each Shared Care Protocol, along with other essential prescribing information to ensure optimum benefit and minimum risk is achieved by the use of each drug.

Responsibility for prescribing between Primary & Secondary/Tertiary Care - Guidance for GPs 

SCP Immunomodulatory therapies in rheumatology/gastroenterology and dermatology conditions  -DMARDS

SCP Modafinil April 2014

SCP Attention Deficit Hyperactivity Disorder (ADHD) April 2017

SCP Hydroxycarbamide Oct 2012

SCP Lithium June 2017

SCP acetylcholinesterase inhibitors and memantine October 2018

SCP Antipsychotics July 18

SCP Dronedarone

SCP Sacubitril/valsartan August 2016

SCP Enoxaparin in at-risk pregnancy and post natal patients (2011)